期刊文献+

曲灵双葛汤治疗酒精性脂肪肝的临床研究 被引量:2

Clincal study of Quling Shuangge decoction on alcoholic fatty liver
下载PDF
导出
摘要 目的评价曲灵双葛汤治疗酒精性脂肪肝的临床疗效。方法选择酒精性脂肪肝78例,按1∶1的比例随机分为治疗组39例,对照组39例。对照组采用常规保肝治疗,治疗组在常规治疗的基础上加用曲灵双葛汤150 mL/次,2次/d,60 d为1个疗程。对比观察2组患者症状、体征变化以及肝功能、血脂水平。治疗前后进行B超检查。结果治疗结束后,治疗组症状、体征均明显改善。胆固醇、三酰甘油、低密度脂蛋白胆固醇、肝功能正常或接近正常,与对照组比较均有显著性差异(P均<0.05)。结论曲灵双葛汤可以缓解酒精性脂肪肝患者的临床症状及体征,改善肝功能及肝脏影像学变化,降低血脂,临床疗效肯定。 Objective It is to evaluate the curative effect of Quling Shuangge decoction on alcoholic fatty liver.Methods 78 patients with alcoholic fatty liver were chosen and randomly divided into treatment group and control group in 1∶1 ratio.39 patients were in treatment group and treated with Quling Shuangge decoction 150 mL for one time and two times a day for 60 days based on conventional therapy.39 patients were in the control group and treated with conventional therapy.The changes of symptom and signs,the liver function and the level of blood fat were compared and observed.Ultrasound examinations were performed in all patients before and after treatment.Results After treatment,the symptom and signs in treatment were all obviously improved.The levels of TC,TG,LDL-C and liver function were normal or almost reached normal.There was significant difference between the two groups(P〈0.05).Conclusion Quling Shuangge decoction can release the clinical symptom and signs of the patients with alcoholic fatty liver,improve the liver function and liver iconography changes and lower the blood fat.The clinical curative effect is affirmative.
作者 贾庆宇
出处 《现代中西医结合杂志》 CAS 2010年第26期3287-3288,3293,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 酒精性脂肪肝 曲灵双葛汤 血清学试验 alcoholic fatty liver Quling Shuangge decoction serological test
  • 相关文献

参考文献2

二级参考文献10

  • 1Thurman RG, Bradford BU, Iimuro Y, et al. The role of gut-derived toxins and free radicals in alcohol-induced liver injury. J Gastroenterol Hepatol, 1998, 13:S39-50.
  • 2Thurman RG. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol, 1998, 275:G605-611.
  • 3Bode C, Schafer C, Fukui H, et al. Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease--a double-blind, placebo-controlled trial. Alcohol Clin Exp Res, 1997,21: 1367-1373.
  • 4Fukui H, Brauner B, Bcde JC, et al. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol, 1991, 12:162-169.
  • 5Adachi Y, Moore LE, Bradford B, et al. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology,1995, 108:218-224.
  • 6Parlesak A, Schafer C, Schutz T, et al. Increased intestinal permeability to macromolecules and endotoxemia in patients with chromic alcohol abuse in diffenrent stages of alcohol-induced liver disease. J Hepatol, 2000, 32:742-747.
  • 7Draper LR, Gyure LA, Hall JG, et al. Effect of alcohol on the integrity of the intestinal epithelium. Gut, 1983, 24: 399-404.
  • 8Bautista AP. Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disese. J Gastroenterol Hepatol, 2000, 15:349-356.
  • 9Schafter C, Greiner B, Landing J, et al. Decreased endotoxin-binding capacity of whole blood in patients with alcoholic liver disease. J Hepatol, 1997, 26:567-573.
  • 10Tuslamoto H, Lin M, Ohata M, et al. Iron primes hepatic macrophages for NF-kappaB activation in alcoholic liver injury. Am J Physiol, 1999, 277:G1240-1250.

共引文献597

同被引文献39

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部